Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00629915 · ClinicalTrials.gov registry record

The Role of Cerebral Hemodynamics in Moyamoya Disease

A clinical trial, sponsored by Washington University School of Medicine.

Completed
Registry status
56
Enrollment target

NCT00629915: Completed study, sponsored by Washington University School of Medicine.

NCT00629915 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00629915 has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
56 participants
Enrollment target

Study Summary

The purpose of this study is to determine if people with moyamoya disease who have insufficient blood flow are at a higher risk for stroke.

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2006-10
Est. Completion 2015-06

What the finished NCT00629915 record still lists

NCT00629915 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 56 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00629915 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00629915 about?

NCT00629915 is a clinical study titled "The Role of Cerebral Hemodynamics in Moyamoya Disease". The purpose of this study is to determine if people with moyamoya disease who have insufficient blood flow are at a higher risk for stroke.

What is the current status of trial NCT00629915?

This trial is currently completed. The enrollment target is 56 participants. The study started on 2006-10. Estimated completion is 2015-06.

Who is sponsoring clinical trial NCT00629915?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00629915, the US trial registry maintained by the National Library of Medicine. NCT00629915 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.